Marty Makary has resigned as the head of the Food and Drug Administration, ending what’s been an unusually tumultuous run steering the U.S.’s top health regulator.
President Trump confirmed Makary’s departure, which was first reported by Politico, at a meeting with reporters on Tuesday. Kyle Diamantas, previously the FDA’s deputy commissioner for food, will serve as the agency’s acting commissioner in Makary’s place.
“Marty's a great guy, he's a friend of mine [and] he's a wonderful man,” Trump said. “He was having some difficulty,” but “he's going to go on and he's going to do well. Everybody wants that job."
The Department of Health and Human Services didn't respond to a request for comment.
Makary was seen as a traditional pick as the head of the FDA when Trump nominated him in November 2024. A prolific medical researcher and author, he wrote papers on topics from pancreatic surgery protocols to patient safety and healthcare costs.
